+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Phase 2
Age: 18Years +
All Genders
ID07145450

Phase 12 Study of Engineered TCR-T Cell Therapy Targeting Mutated KRAS in Adults With Metastatic or Locally Advanced Pancreatic Ductal Adenocarcinoma

Led by Anocca AB · Updated on 2026-06-08

96

Participants Needed

10

Research Sites

17 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating engineered autologous T cell therapies designed to recognize specific mutated KRAS proteins in combination with human leukocyte antigen HLA in adults with metastatic or locally advanced pancreatic ductal adenocarcinoma PDAC. This open-label, phase 12 trial studies the safety, expansion, persistence, and anti-tumor activity of these T cell products following standard first-line therapy. The study includes three sub-studies targeting different KRAS mutations G12V and G12D. The treatment involves collecting a participants T cells through leukapheresis, followed by lymphodepleting chemotherapy with cyclophosphamide and fludarabine. Then, participants receive a single intravenous infusion of gene-edited TCR-T cells targeting their specific KRAS mutation and HLA type. The study uses a dose escalation design to determine the optimal safe dose. The trial is divided into two parts screening and enrollment, then treatment and follow-up. Participants undergo detailed assessments including imaging scans to measure disease, safety evaluations for adverse events and dose-limiting toxicities, and monitoring of T cell expansion and persistence over 24 months. Outcome measures include response rates, clinical benefit, progression-free survival, and overall survival. The study involves regular monitoring from leukapheresis through treatment and follow-up to assess safety and clinical activity.

CONDITIONS

Brief Title

Master Protocol of TCR-modified T Cell Therapy Targeting HLA-restricted KRAS Antigen Administered in Adult Patients With Metastatic or Locally Advanced PDAC

Research Team

A

Amu Wang

A

Anocca AB

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here